Try it
Pharmacology · Chemotherapy: P-glycoprotein multidrug resistance
Sample itemA lymphoma that responded to doxorubicin relapses and is now resistant to doxorubicin, vincristine and paclitaxel, drugs with different structures and targets. Which mechanism best explains this pattern?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. Overexpression of the P-glycoprotein efflux pump
Multidrug resistance occurs when the MDR1 gene product P-glycoprotein pumps natural-product drugs such as anthracyclines, vinca alkaloids, taxanes and etoposide out of the cell. Cross-resistance to structurally unrelated drugs is the clue. Antimetabolite resistance usually involves target-enzyme changes.
Option by option
A. Overexpression of the P-glycoprotein efflux pump (correct)
Correct. P-glycoprotein effluxes anthracyclines, vinca alkaloids and taxanes together.
B. Increased expression of thymidylate synthase
Increased thymidylate synthase causes resistance to fluorouracil.
C. Higher activity of the DNA repair enzyme MGMT
Higher MGMT activity causes resistance to alkylating agents such as temozolomide and nitrosoureas.
D. Amplification of the dihydrofolate reductase gene
DHFR amplification causes resistance to methotrexate and not to this group of drugs.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?